APGE - Apogee Therapeutics, Inc.
73.05
2.130 2.916%
Share volume: 607,065
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.19%
PREVIOUS CLOSE
CHG
CHG%
$70.92
2.13
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-13-2024 | 08-12-2024 | 11-12-2024 | 03-03-2025 | 05-12-2025 | 11-10-2025 | 03-02-2026 | |
| Cash flow financing | 450.520 M | -150.000 K | 383.000 K | 44.356 M | 622.000 K | 19.738 M | 374.950 M | |
| Other financing cash flows | 24.000 K | 391.000 K | 383.000 K | 828.000 K | 622.000 K | 356.000 K | 4.698 M | |
| Cash flow | 367.141 M | -178.158 M | -188.519 M | 23.009 M | -34.873 M | -16.572 M | 23.635 M | |
| Net income | -32.094 M | -33.816 M | -49.018 M | -67.218 M | -55.339 M | -65.021 M | -69.387 M | |
| Depreciation | 29.000 K | 36.000 K | 48.000 K | 76.000 K | 207.000 K | 406.000 K | 406.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -51.743 M | -148.708 M | -146.378 M | 46.367 M | 12.982 M | 17.945 M | -288.626 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 351.000 K | 51.000 K | 751.000 K | -1.000 K | 4.317 M | 0.000 | 62.000 K | |
| Cash Change | 367.141 M | -178.158 M | -188.519 M | 23.009 M | -34.873 M | -16.572 M | 23.635 M |